FDA Approves New Oral Gonorrhea Treatment
The FDA approval of zoliflodacin and gepotidacin introduces two new oral treatment options for uncomplicated urogenital gonorrhea in adolescents and
Learn More
![FDA-Authorized Teal Wand: Clinical Overview]()
FDA-Authorized Teal Wand: Clinical Overview
In May 2025, the U.S. Food and Drug Administration (FDA) authorized the Teal Wand, the first prescription, at-home vaginal self-collection
Learn More
